Sign in to view content

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA

W. Lloyd Clark, MD, FASRS

Video
Published 2019

W. Lloyd Clark, MD

Diabetic Retinopathy Part I Symposium

Related

Faricimab Response is Associated With Intraocular Pressure Lowering in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Tamara L Lenis, MD, PhD
Annual Meeting Talks
2024
Silicone Oil (SO) Microdroplets in Repackaged Bevacizumab Syringes: Identification, Quantification, and Strategies For Reducing Clincal Impact
John D Pitcher, MD
On Demand Cases, Courses, and Papers
2017
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

See more